Intuitive Surgical (NASDAQ:ISRG) shares maintained their Buy rating and a $561.00 price target from BTIG, despite potential ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.65% of ...

Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $2.07 which represents a slight increase of $0.14 or 7.25% from the prior close of $1.93. The stock opened at $1.95 and ...

Prologis (NYSE:PLD – Get Free Report) had its price objective cut by analysts at BTIG Research from $154.00 to $134.00 in a report released on Friday. The brokerage currently has a “buy” rating on the ...

Tuesday, shares of Ideaya Biosciences (NASDAQ:IDYA), trading at $22.18 near its 52-week low of $22.10, drew attention as BTIG analysts maintained their Buy rating and $62.00 price target. According to ...

Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

Warby Parker Inc. (NYSE:WRBY – Get Free Report) shares dropped 6.6% during trading on Friday . The company traded as low as ...

BTIG raised the firm’s price target on Akebia (AKBA) to $10 from $5 and keeps a Buy rating on the shares. The firm cites the company’s Vafseo ...

BTIG raised the firm’s price target on AppLovin (APP) to $437 from $432 and keeps a Buy rating on the shares ahead of its Q4 results. The firm ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they could rally this year.

to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical Technology names. BTIG is increasing its estimates for U.S ...